There’s no doubt that the demand for fat reduction treatments is high among consumers—fat reduction was the most in-demand non-surgical aesthetic treatment in 2018 after injectables, according to the American Society for Aesthetic Plastic Surgery (ASAPS)1. However, as a medical aesthetics provider, getting rid of the fat is just half of the battle. To fully satisfy your patients’ body aesthetics goals, you also need to tighten lax skin and further contour the body. This is why you should be augmenting your fat reduction results with skin tightening treatments.
Trim & Tite™ is a new and effective skin tightening solution offered by Venus Legacy™ that works to ensure your patients have superior clinical results than with just fat reduction treatments alone. Trim & Tite™ can be used as a complementary treatment after any mode of fat reduction or weight loss to tighten the skin, further slim body circumference, and smooth out demarcations where focal fat was not evenly reduced, ensuring even greater patient satisfaction.
An advanced medical aesthetic system for non-invasive skin tightening. Equipped with four different applicators, the device also offers treatments for non-surgical circumferential reduction, cellulite reduction, and wrinkle reduction to address patients' most challenging face and body aesthetic needs.
As effectiveas they are, fat reduction and weight loss treatment plans can leave behind loose, lax skin on the abdomen. Treatments with Venus Legacy™ can help improve the appearance of excess skin in this area by further stimulating fat breakdown and increasing collagen synthesis.
Results after: 5 Venus Legacy™ treatments
Courtesy of Robin Hamlin, MD
INDICATIONS FOR USE:
Venus Legacy™ has CE Mark for the increase of skin tightening, temporary circumferential reduction, cellulite reduction, and wrinkle reduction.
1. American Society for Aesthetic Plastic Surgery (ASAPS) 2018 Cosmetic (Aesthetic) Surgery National Data Bank. Data were collected from 315 board-certified plastic surgeons through a questionnaire in 2018.